Therefore, it would be interesting to characterize the expression of ZMIZ1 and different length polyQ AR in patient samples of prostate cancer, AIS, and other human disorders that may be closely related to either loss or gain-of-function mutations in the AR gene. The gene discussed is AR; the disease is androgen insensitivity syndrome.